Education
About Us
Working with TipRanks
Follow Us
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
KRMD Stock Chart & Stats
$4.77
<$0.01(0.25%)
At close: 4:00 PM EST
$4.77
<$0.01(0.25%)
Day’s Range― - ―
52-Week Range$1.86 - $6.61
Previous CloseN/A
Volume31.78K
Average Volume (3M)198.68K
Market Cap
$220.96M
Enterprise Value$216.17M
Total Cash (Recent Filing)$8.46M
Total Debt (Recent Filing)$3.67M
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Mar 12, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding46,322,655
10 Day Avg. Volume166,933
30 Day Avg. Volume198,682
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)10.49
Price to Sales (P/S)5.24
P/FCF Ratio-109.04
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue5.53
Enterprise Value/Gross Profit8.88
Enterprise Value/Ebitda-67.59
Forecast
1Y Price Target
$6.33Price Target Upside32.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)-0.02
Revenue Forecast (FY)$48.48M
Bulls Say, Bears Say
Bulls Say
International Market ExpansionThe substantial growth in international markets, particularly in Europe, indicates a successful expansion strategy that could provide a durable revenue stream and reduce dependency on domestic markets.
Core Business PerformanceThe strong growth in the SCIG business highlights the company's competitive advantage in a niche market, supporting long-term revenue growth and market leadership in infusion therapy.
Increased Revenue GuidanceThe increased revenue guidance reflects management's confidence in sustained growth, driven by strategic initiatives and market demand, which is crucial for long-term financial health.
Bears Say
Gross Margin ChallengeThe decline in gross margin indicates potential challenges in cost management, which could pressure profitability and affect the company's ability to reinvest in growth.
Cash Flow ManagementThe sharp decline in free cash flow growth suggests difficulties in converting revenue into cash, which may limit the company's operational flexibility and investment capacity.
Pipeline Launch DelaysDelays in pipeline launches can hinder future revenue streams and slow down strategic growth initiatives, affecting long-term competitive positioning.
REPRO-MED Systems News
KRMD FAQ
What was REPRO-MED Systems’s price range in the past 12 months?
REPRO-MED Systems lowest stock price was $1.86 and its highest was $6.61 in the past 12 months.
What is REPRO-MED Systems’s market cap?
REPRO-MED Systems’s market cap is $220.96M.
When is REPRO-MED Systems’s upcoming earnings report date?
REPRO-MED Systems’s upcoming earnings report date is Mar 12, 2026 which is in 9 days.
How were REPRO-MED Systems’s earnings last quarter?
REPRO-MED Systems released its earnings results on Nov 12, 2025. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.024 by $0.004.
Is REPRO-MED Systems overvalued?
According to Wall Street analysts REPRO-MED Systems’s price is currently Undervalued.
Does REPRO-MED Systems pay dividends?
REPRO-MED Systems does not currently pay dividends.
What is REPRO-MED Systems’s EPS estimate?
REPRO-MED Systems’s EPS estimate is -0.02.
How many shares outstanding does REPRO-MED Systems have?
REPRO-MED Systems has 46,322,655 shares outstanding.
What happened to REPRO-MED Systems’s price movement after its last earnings report?
REPRO-MED Systems reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.024. Following the earnings report the stock price went up 15.079%.
Which hedge fund is a major shareholder of REPRO-MED Systems?
Currently, no hedge funds are holding shares in KRMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
REPRO-MED Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
50.99%
12-Months-Change
Fundamentals
Return on Equity
-21.71%
Trailing 12-Months
Asset Growth
-1.05%
Trailing 12-Months
Company Description
REPRO-MED Systems
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
KRMD Company Deck
KRMD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, particularly from international markets, and successful strategic advancements in oncology and other areas. However, challenges such as domestic revenue decline, gross margin pressure, and some pipeline delays were noted.View all KRMD earnings summariesKRMD Stock 12 Month Forecast
Average Price Target
$6.33
▲(32.70% Upside)
Technical Analysis
InfuSystem Holdings
―
Orasure Technologies
―
Utah Medical Products
―
Microbot Medical
―
Sharps Technology, Inc.
―
Ownership Overview
17.04% Insiders
8.22% Mutual Funds
24.31% Other Institutional Investors
42.86% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---